PCRX FY 2017 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$969M

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$287M+3.7% YoY

Gross Profit

$199M69.3% margin

Operating Income

-$25M-8.7% margin

Net Income

-$43M-14.9% margin

EPS (Diluted)

$-1.07

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

-$1M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$628M

Total Liabilities

$349M

Stockholders' Equity

$279M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$287M	$276M	+3.7%
Gross Profit	$199M	$166M	+19.5%
Operating Income	-$25M	-$32M	+22.1%
Net Income	-$43M	-$38M	-12.3%